|
|
Article: IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005.
- Article from:
- Business Wire
- Article date:
- May 2, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HAYWARD, Calif. -- First graph, first sentence of release should read: xxx a generic version of Rimadyl(R) (Carpofen) 25, 75 and 100 mg Caplets (sted xxx a generic version of Rimadyl(R) (Carpofen) 25, 50 and 75 mg Caplets).
The corrected release reads:
IMPAX RECEIVES FDA APPROVAL FOR GENERIC VERSION OF RIMADYL, A VETERINARY PRODUCT; FOURTH APPROVAL IN 2005
IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the Company's Abbreviated New Animal Drug Application (ANADA) for a generic version of Rimadyl(R) (Carpofen) 25, 75 and 100 mg Caplets. Pfizer Animal Health ...